common.study.topics.clinical
Golimumab for Adherence in Rheumatoid Arthritis
common.study.values.description
“Golimumab for Adherence in Rheumatoid Arthritis”
The purpose of this study is to determine if non-adherence to Rheumatoid Arthritis (RA) drugs in participants treated with biologic disease modifying anti-rheumatic drugs (DMARDs) is associated with a greater incidence of disease in clinical practice.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-no
common.study.methods.is-healthy-yes
Biological - Golimumab
Participants will receive golimumab as a part of clinical practice.
participant.views.study.view.additional
participant.views.study.view.scientific-title
Golimumab for Adherence in Rheumatoid Arthritis
common.study.values.clinical-trial-id
NCT03729349
participant.views.study.view.id
e1wYjb
